SCHEMBL1891935

SCHEMBL1891935

Cc1nc(NC(=O)NCCC(=O)OC(C)(C)C)sc1-c1ccncc1

nearest known ligand 0.67

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
PIK3CG P48736 12/20 0.67
PIK3CD O00329 8/20 0.67
PIK3CA P42336 5/20 0.67
PIK3CB P42338 5/20 0.67
PI4KB Q9UBF8 7/20 0.57
PI4KA P42356 1/20 0.47
DYRK3 O43781 1/20 0.46
MAP4K4 O95819 1/20 0.46
CLK2 P49760 1/20 0.46
DYRK1A Q13627 1/20 0.46
MINK1 Q8N4C8 1/20 0.46
CLK4 Q9HAZ1 1/20 0.46
ABL1 P00519 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12992468 0.91 PIK3CD (0.68) PIK3CGPIK3CDPIK3CAPIK3CBPI4KB
SCHEMBL1883394 0.87 PIK3CG (0.54) PIK3CGPIK3CDPIK3CAPIK3CBPI4KB
SCHEMBL1786151 0.86 PIK3CD (0.76) PIK3CGPIK3CDPIK3CAPIK3CBPI4KB
SCHEMBL12992192 0.86 PIK3CD (0.50) PIK3CGPIK3CDPIK3CAPIK3CBPI4KB
SCHEMBL12991834 0.85 PIK3CG (0.77) PIK3CGPIK3CDPIK3CAPIK3CBPI4KB
SCHEMBL3842187 0.82 PIK3CG (0.50) PIK3CGPIK3CDPIK3CAPIK3CBPI4KB
SCHEMBL12991289 0.82 PIK3CG (0.54) PIK3CGPIK3CDPIK3CAPIK3CBPI4KB
SCHEMBL1889391 0.82 PIK3CG (0.55) PIK3CGPIK3CDPIK3CAPIK3CBPI4KB
SCHEMBL14407093 0.82 PIK3CG (0.63) PIK3CGPIK3CDPIK3CAPIK3CBPI4KB
SCHEMBL12991903 0.81 PIK3CG (0.67) PIK3CGPIK3CDPIK3CAPIK3CBPI4KB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2157091-B1 Inhibitors of phosphatidylinositol 3-kinase NOVARTIS AG (CH) 2015-06-10 EP disclosed
US-20130172349-A1 INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE NOVARTIS AG (CH) 2013-07-04 US disclosed
US-8404684-B2 Inhibitors of phosphatidylinositol 3-kinase NOVARTIS AG (CH) 2013-03-26 US disclosed
US-20110105535-A1 INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE NOVARTIS AG 2011-05-05 US disclosed
EP-2157091-A1 Inhibitors of phosphatidylinositol 3-kinase Novartis AG (CH) 2010-02-24 EP disclosed
EP-1622897-B1 INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE NOVARTIS AG (CH) 2009-10-14 EP disclosed
US-20070032487-A1 Inhibitors of phosphatidylinositol 3-kinase NOVARTIS AG (CH) 2007-02-08 US disclosed
EP-1622897-A1 INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE Novartis AG (CH) 2006-02-08 EP disclosed
WO-2004096797-A1 INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE NOVARTIS AG (CH) 2004-11-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070032487-A1 Inhibitors of phosphatidylinositol 3-kinase PIK3CA, PIP4K2C, PIP4K2B PIK3CG 10/4885PIK3CD 4/4885PIK3CA 1/4885
US-20110105535-A1 INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE PIK3CA, PIK3CD, PIP4K2C PIK3CG 8/4885PIK3CD 2/4885PIK3CA 1/4885
US-20130172349-A1 INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE PIK3CA, PIK3CD, PIP4K2C PIK3CG 8/4885PIK3CD 2/4885PIK3CA 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.